Xia Xu

The Application of MSCs-Derived Extracellular Vesicles in Bone Disorders: Novel Cell-Free Therapeutic Strategy

A. Qian, Lifang Hu, Zhihao Chen, 2020, Frontiers in Cell and Developmental Biology.

miR-138–5p negatively regulates osteoblast differentiation through inhibiting β-catenin under simulated microgravity in MC3T3-E1 cells

A. Qian, Lifang Hu, Ye Tian, 2021 .

MiR-138-5p Targets MACF1 to Aggravate Aging-related Bone Loss

Chaofei Yang, A. Qian, Lifang Hu, 2022, International journal of biological sciences.

CDK12: A Potent Target and Biomarker for Human Cancer Therapy

A. Qian, Lifang Hu, Zhihao Chen, 2020, Cells.

Piezo Channels: Awesome Mechanosensitive Structures in Cellular Mechanotransduction and Their Role in Bone

A. Qian, Lifang Hu, K. Ru, 2021, International journal of molecular sciences.

Inhibition of SPRY2 expression protects sevoflurane-induced nerve injury via ERK signaling pathway

Xia Xu, Lin Hu, Jianan Du, 2022, Tropical Journal of Pharmaceutical Research.

MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm

A. Qian, Lifang Hu, Yi Zhang, 2021, Cell Death & Differentiation.

Ellagic acid inhibits CDK12 to increase osteoblast differentiation and alleviate osteoporosis in hindlimb-unloaded and ovariectomized mice.

A. Qian, Lifang Hu, Wenjuan Zhang, 2023, Phytomedicine : international journal of phytotherapy and phytopharmacology.